Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride

• Status: Completed
• Trial end date: 2020-05-10
• Target enrollment: 0
• Participant gender: All

Summary

study the effect of omega 3 fatty acids on blood glucose, lipids profile, serum Irisin and sirtuin-1 in type 2 diabetic mellitus patients treated with glimepiride.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Damanhour University
• Treatments: Glimepiride

Criteria

Inclusion Criteria:

• 70 Adult patients aged 30-60 years old with type 2 diabetes mellitus treated with glimepiride.

• glycated hemoglobin percent greater than 7%.

• body mass index between 25 and 35 kg/m2.

• Patients who are not consuming omega-3 fatty acids, supplements or any pharmaceutical products that may interact with their lipid profile.

Exclusion Criteria:

• Pregnant or lactating women.

• Have gastrointestinal disorders that interfere with the bowel function

• patients with severe hepatic, renal, inflammatory and thyroid diseases.

• insulin therapy.

• Have diabetes complications including micro and macrovascular complications.

• Alcoholics and patients with past history of drug abuse.